ANDA 204829, held by Pharmobedient. Cyanocobalamin.
As of Nov 15, 2026, ANDA 204829 (Cyanocobalamin), held by Pharmobedient, was first approved by FDA on Jun 5, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 5, 2017 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyanocobalamin1MG/ML ยท injectable;injection | Cyanocobalamin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
